SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001811764-22-000017
Filing Date
2022-02-25
Accepted
2022-02-25 08:39:46
Documents
54

Document Format Files

Seq Description Document Type Size
1 424B3 a424b3combinedxfebruary252.htm 424B3 33470
2 EX-99.1 exhibit991-pointbiopharm.htm EX-99.1 50654
3 EX-99.2 exhibit992-20220225xdosi.htm EX-99.2 10475
4 exhibit991-pointbiopharm001.jpg GRAPHIC 109251
5 exhibit991-pointbiopharm002.jpg GRAPHIC 207014
6 exhibit991-pointbiopharm003.jpg GRAPHIC 95985
7 exhibit991-pointbiopharm004.jpg GRAPHIC 117986
8 exhibit991-pointbiopharm005.jpg GRAPHIC 102301
9 exhibit991-pointbiopharm006.jpg GRAPHIC 90385
10 exhibit991-pointbiopharm007.jpg GRAPHIC 103309
11 exhibit991-pointbiopharm008.jpg GRAPHIC 81142
12 exhibit991-pointbiopharm009.jpg GRAPHIC 119889
13 exhibit991-pointbiopharm010.jpg GRAPHIC 130908
14 exhibit991-pointbiopharm011.jpg GRAPHIC 118085
15 exhibit991-pointbiopharm012.jpg GRAPHIC 120636
16 exhibit991-pointbiopharm013.jpg GRAPHIC 82215
17 exhibit991-pointbiopharm014.jpg GRAPHIC 119674
18 exhibit991-pointbiopharm015.jpg GRAPHIC 58228
19 exhibit991-pointbiopharm016.jpg GRAPHIC 118604
20 exhibit991-pointbiopharm017.jpg GRAPHIC 102001
21 exhibit991-pointbiopharm018.jpg GRAPHIC 117409
22 exhibit991-pointbiopharm019.jpg GRAPHIC 114998
23 exhibit991-pointbiopharm020.jpg GRAPHIC 111582
24 exhibit991-pointbiopharm021.jpg GRAPHIC 77807
25 exhibit991-pointbiopharm022.jpg GRAPHIC 78470
26 exhibit991-pointbiopharm023.jpg GRAPHIC 98028
27 exhibit991-pointbiopharm024.jpg GRAPHIC 92139
28 exhibit991-pointbiopharm025.jpg GRAPHIC 93269
29 exhibit991-pointbiopharm026.jpg GRAPHIC 82474
30 exhibit991-pointbiopharm027.jpg GRAPHIC 73863
31 exhibit991-pointbiopharm028.jpg GRAPHIC 92535
32 exhibit991-pointbiopharm029.jpg GRAPHIC 75350
33 exhibit991-pointbiopharm030.jpg GRAPHIC 105915
34 exhibit991-pointbiopharm031.jpg GRAPHIC 104867
35 exhibit991-pointbiopharm032.jpg GRAPHIC 101346
36 exhibit991-pointbiopharm033.jpg GRAPHIC 96312
37 exhibit991-pointbiopharm034.jpg GRAPHIC 98596
38 exhibit991-pointbiopharm035.jpg GRAPHIC 91538
39 exhibit991-pointbiopharm036.jpg GRAPHIC 84427
40 exhibit991-pointbiopharm037.jpg GRAPHIC 108141
41 exhibit991-pointbiopharm038.jpg GRAPHIC 97227
42 exhibit991-pointbiopharm039.jpg GRAPHIC 95836
43 exhibit991-pointbiopharm040.jpg GRAPHIC 46129
44 exhibit991-pointbiopharm041.jpg GRAPHIC 112020
45 exhibit991-pointbiopharm042.jpg GRAPHIC 104093
46 exhibit991-pointbiopharm043.jpg GRAPHIC 74650
47 exhibit991-pointbiopharm044.jpg GRAPHIC 40765
48 exhibit991-pointbiopharm045.jpg GRAPHIC 82320
49 exhibit991-pointbiopharm046.jpg GRAPHIC 119692
50 exhibit991-pointbiopharm047.jpg GRAPHIC 110888
51 exhibit992-20220225xdosi001.jpg GRAPHIC 255438
52 exhibit992-20220225xdosi002.jpg GRAPHIC 288425
53 exhibit992-20220225xdosi003.jpg GRAPHIC 312853
54 image_0a.jpg GRAPHIC 7287
  Complete submission text file 0001811764-22-000017.txt   7709486
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258325 | Film No.: 22674711
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences